SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-018553
Filing Date
2023-03-08
Accepted
2023-03-08 16:16:46
Documents
14
Period of Report
2023-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea174846-8k_optimizerx.htm   iXBRL 8-K 25095
2 PRESS RELEASE, DATED MARCH 8, 2023 ea174846ex99-1_optimizerx.htm EX-99.1 110810
3 GRAPHIC ex99-1_001.jpg GRAPHIC 13911
  Complete submission text file 0001213900-23-018553.txt   342471

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE oprx-20230308.xsd EX-101.SCH 3233
5 XBRL LABEL FILE oprx-20230308_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE oprx-20230308_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea174846-8k_optimizerx_htm.xml XML 3591
Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 23716334
SIC: 7389 Services-Business Services, NEC